DD

Rating buyTentativeAI MemoPost-earnings T+3

DuPont de Nemours

As of 2026-05-08/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-08 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators; memo remains a monitoring view with limited forward evidence and should not be standard-conviction

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Annual-meeting reverse-split decision remains a governance and optics event • 2026-05-30

Expected move: -60%

Biggest risk

The follow-up still looks more like a monitored beat-and-raise than a clean re-rating: Water Technologies faced Middle East logistics disruption, Building Technologies remained weak, and the company still carries portfolio-transition, reverse-split, and PFAS overhangs [#8-K-2026-05-05] [#10-Q-2026-05-05]. The peer set is also loose for DuPont's current portfolio, and consensus estimate or target-change evidence was not fully available in the checked evidence, limiting conviction.

Invalidation

Break below $43 or thesis failure.

What would change my mind?

The strongest post-earnings read-through is that DuPont both beat its own Q1 setup and raised full-year guidance, with management citing organic growth, margin expansion, lower interest expense, and pricing actions to offset higher input costs tied to the Middle East conflict [#8-K-2026-05-05]. Immediate market reaction was favorable, and secondary coverage suggests a positive initial tone after the print, but the available packet does not provide enough confirmed analyst-revision breadth for a stronger call.

Research note

Recommendation

buy

Confidence

medium

As of

2026-05-08

Base target

$55

p=45%

Bull target

$60

p=30%

Bear target

$43

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Q1 beat, raised FY2026 outlook, and imminent $275M ASR launch
Aramids divestiture proceeds and portfolio reset create capital-allocation upside, but execution must follow through
The strongest post-earnings read-through is that DuPont both beat its own Q1 setup and raised full-year guidance, with management citing organic growth, margin expansion, lower interest expense, and pricing actions to offset higher input costs tied to the Middle East conflict [#8-K-2026-05-05].

BearKey bullets

Building Technologies organic sales were down low-single digits because of ongoing weakness in construction markets [#8-K-2026-05-05].
Capital-allocation upside from the Aramids sale and buyback authorization depends on execution; buyback timing and completion are not guaranteed [#8-K-2026-05-05] [#10-Q-2026-05-05].
PFAS cost-sharing and litigation remain a material long-tail risk; the 10-Q says additional eligible PFAS costs above accrued amounts are reasonably possible [#10-Q-2026-05-05].

WatchKey bullets

Annual-meeting reverse-split decision remains a governance and optics event

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $55 (p=45%)

Bull/Bear spread: -57% / -69%

Vs latest close: Bull -57% · Base -60% · Bear -69%

Scenario probabilities

Bull Target: $60 (p=30%)Base Target: $55 (p=45%)Bear Target: $43 (p=25%)

Commentary

Tone improved after the May 5, 2026 earnings release because the company beat its own setup, raised full-year guidance, and announced an imminent ASR [#8-K-2026-05-05]. Reuters-linked coverage indicated an immediate post-print rally of roughly 9% on May 5, and the May 7 anchor price of $48.36 still sits below the packet's $56.125 median target. However, this was a T+3 follow-up with incomplete analyst-revision breadth and a loose peer set, so the sentiment read remains positive but explicitly tentative and monitoring-oriented rather than standard-conviction.

As of 2026-05-08 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Q1 beat, raised FY2026 outlook, and imminent $275M ASR launch
Aramids divestiture proceeds and portfolio reset create capital-allocation upside, but execution must follow through

Scenarios

Bull Target (Scenario probability)

$60 / p=30% prob

Base Target (Scenario probability)

$55 / p=45% prob

Bear Target (Scenario probability)

$43 / p=25% prob

Price $139 as of 2026-07-21

Nearest Scenario: Bull (∆ 57%)

Targets vs latest close: Bull -57% · Base -60% · Bear -69%

Sentiment & Exposure

News Sentiment (30d)

0.62

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-05-30
Annual-meeting reverse-split decision remains a governance and optics event
The 10-Q says DuPont plans to seek stockholder approval for a reverse stock split at a ratio between 1-for-2 and 1-for-4, with implementation left to board discretion; approval or pushback could affect trading optics and investor interpretation even if it does not change fundamentals [#10-Q-2026-05-05].
Prob 65.00% • Move 6.00% • Priced-in 35.00%

Short-term Catalysts

Next few weeks

Q1 beat, raised FY2026 outlook, and imminent $275M ASR launch
2026-06-30
DuPont reported Q1 net sales of $1.681 billion, adjusted EPS of $0.55, operating EBITDA of $414 million, said results exceeded its own first-quarter guidance, raised full-year 2026 guidance to net sales of $7.155-$7.215 billion, operating EBITDA of $1.73-$1.76 billion, and adjusted EPS of $2.35-$2.40, and said a $275 million accelerated share repurchase is expected to launch imminently [#8-K-2026-05-05] [#10-Q-2026-05-05].
Prob 80% • Move 9% • Priced-in 60%

Long-term Catalysts

Months to a year

Aramids divestiture proceeds and portfolio reset create capital-allocation upside, but execution must follow through
2026-12-31
DuPont completed the Aramids divestiture on April 1, 2026 for about $1.2 billion of pre-tax cash proceeds plus a $300 million note and equity consideration, while maintaining a broader $2 billion buyback authorization; sustained shareholder value now depends on disciplined redeployment, buybacks, and continued margin execution in the remaining portfolio [#8-K-2026-05-05] [#10-Q-2026-05-05].
Prob 60% • Move 10% • Priced-in 45%

Risks

Building Technologies organic sales were down low-single digits because of ongoing weakness in construction markets [#8-K-2026-05-05].
Capital-allocation upside from the Aramids sale and buyback authorization depends on execution; buyback timing and completion are not guaranteed [#8-K-2026-05-05] [#10-Q-2026-05-05].
PFAS cost-sharing and litigation remain a material long-tail risk; the 10-Q says additional eligible PFAS costs above accrued amounts are reasonably possible [#10-Q-2026-05-05].
Reverse-stock-split approval and execution could create governance and market-structure noise even if operating performance remains intact [#10-Q-2026-05-05].
The available peer set is too broad to cleanly benchmark DuPont's post-restructuring portfolio, so relative valuation and margin conclusions should be treated cautiously.
Water Technologies faced logistics disruptions in the Middle East, and management is relying on pricing to offset higher input costs related to the conflict [#8-K-2026-05-05].

Peers

Symbol	Summary
DOW	Best available operating comparator from the packet and prior baseline for large-cap chemicals, industrial demand, pricing, and capital allocation, but it is more commodity-exposed than DuPont's post-restructuring specialty portfolio.
IFF	Candidate-set specialty-materials comparator for margin quality and end-market mix, though it is not a direct product overlap and should be treated as a loose valuation and margin reference only.
ALB	Prior-baseline specialty-chemicals comparator used only for growth, pricing, and portfolio-transition context; lithium exposure makes it an imperfect peer, reinforcing that the peer set is not strong enough to support standard-conviction conclusions.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Human targets: serper
Analysis date: 2026-05-08

AI Stock Memo: DD - DuPont de Nemours - RankAlpha